(Q34551192)

3 August 2017

Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802. (English)

1 reference

3 August 2017

phase III clinical trial

0 references

0 references

4

Joseph H Antin

1 reference

3 August 2017

8

Elizabeth O Hexner

1 reference

3 August 2017

10

Stephanie J Lee

1 reference

3 August 2017

12

Margaret L MacMillan

1 reference

3 August 2017

13

Paul J Martin

1 reference

3 August 2017

Javier Bolaños-Meade

1

1 reference

3 August 2017

Brent R Logan

2

1 reference

3 August 2017

Amin M Alousi

3

1 reference

3 August 2017

Kate Barowski

5

1 reference

3 August 2017

Shelly L Carter

6

1 reference

3 August 2017

Steven C Goldstein

7

1 reference

3 August 2017

Mary M Horowitz

9

1 reference

3 August 2017

John E Levine

11

1 reference

3 August 2017

Adam M Mendizabal

14

1 reference

3 August 2017

Ryotaro Nakamura

15

1 reference

3 August 2017

Marcelo C Pasquini

16

1 reference

3 August 2017

Daniel J Weisdorf

17

1 reference

3 August 2017

Peter Westervelt

18

1 reference

3 August 2017

Vincent T Ho

19

1 reference

3 August 2017

language of work or name

English

0 references

publication date

28 August 2014

1 reference

3 August 2017

1 reference

3 August 2017

124

1 reference

3 August 2017

22

1 reference

3 August 2017

3221-7; quiz 3335

1 reference

ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239331

Peripheral-blood stem cells versus bone marrow from unrelated donors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239331

Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239331

Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239331

A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239331

Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239331

A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239331

1994 Consensus Conference on Acute GVHD Grading

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239331

Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239331

Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239331

Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239331

Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239331

Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239331

Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25170121

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25170121

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1182/BLOOD-2014-06-577023

1 reference

3 August 2017

1 reference

3 August 2017

1 reference